Actos Lawsuits Claim Drug Is Defective, Can Cause Bladder Cancer

Last Updated on May 1, 2020

Investigation Complete

Comments |

At A Glance

This Alert Affects
Patients who were diagnosed with bladder cancer after taking any of the following diabetes drugs: Actos, ActoPlus Met, ActoPlus Met XR or Duetact.
Side Effects
Bladder cancer
Takeda Pharmaceuticals
Intended Use
Actos, ActoPlus Met, ActoPlus Met XR and Duetact contain pioglitazone, an oral diabetes medication that helps control blood sugar levels and has been linked to bladder cancer.
FDA Warning
The FDA issued a warning regarding Actos and its potential link to bladder cancer on June 15, 2011.
What Can I Recover?
Medical bills, lost wages, compensation for pain and suffering
Type of Lawsuit
Mass Tort